(Q81533674)
Statements
Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation (English)
Zeiser R
Spyridonidis A
Wäsch R
Ihorst G
Grüllich C
Bertz H